Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment

    January 2024 in “ Skin Appendage Disorders
    Anabella Watts‐Santos, David Ancona‐Lezama, Jose A Figueroa-Sanchez … Verónica Garza-Rodríguez
    Studysummary This article discusses ciliary madarosis as a transient condition secondary to IAC, emphasizing the value of physical and trichoscopic evaluations for diagnosis and prognosis; it does not report new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pmc.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Eyebrow and Eyelash Alopecia: A Clinical Review American journal of clinical dermatology · 2022
    2. Pathogenesis and Treatment Options for Chemotherapy-Induced Alopecia: A Systematic Review International Journal of Dermatology · 2018
    3. Madarosis: A Qualitative Study to Assess Perceptions and Experience of Australian Patients with Early Breast Cancer Treated with Taxane-Based Chemotherapy Supportive care in cancer · 2017
    4. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013